Attach to Form 990 or Form 990-EZ.
Information about Schedule A (Form 990 or 990-EZ) and its instructions is at www.irs.gov/form990.
| (i)Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 9 above or IRC section (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
| Total | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2010 | (b) 2011 | (c) 2012 | (d) 2013 | (e) 2014 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .... | ||||||
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf....... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | ||||||
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. | ||||||
| 6 | Public support. Subtract line 5 from line 4. | ||||||
Calendar year
(or fiscal year beginning in) ![]() |
(a) 2010 | (b) 2011 | (c) 2012 | (d) 2013 | (e) 2014 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | ||||||
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | ||||||
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support Add lines 7 through 10. | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2010 | (b) 2011 | (c) 2012 | (d) 2013 | (e) 2014 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | 1,240,443 | 665,428 | 1,905,871 | |||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose...... | 5,902,814 | 9,239,042 | 15,141,856 | |||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513.. | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 6 | Total. Add lines 1 through 5. | 7,143,257 | 9,904,470 | 17,047,727 | |||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons... | 1,240,443 | 652,818 | 1,893,261 | |||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | 1,240,443 | 652,818 | 1,893,261 | |||
| 8 | Public support (Subtract line 7c from line 6.) | 15,154,466 | |||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2010 | (b) 2011 | (c) 2012 | (d) 2013 | (e) 2014 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | 7,143,257 | 9,904,470 | 17,047,727 | |||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | 11,121 | 72,137 | 83,258 | |||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | 11,121 | 72,137 | 83,258 | |||
| 11 | Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | 0 | 0 | 7,154,378 | 9,976,607 | 17,130,985 | |
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e | Discount claimed for blockage or other factors (explain in detail in Part VI): | |||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 1-1/2% of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by .035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| 7 | Check here if the current year is the organization's first as a non-functionally-integrated Type III supporting organization (see instructions) | |||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | ||
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
||
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | ||
| 4 Amounts paid to acquire exempt-use assets | ||
| 5 Qualified set-aside amounts (prior IRS approval required) | ||
| 6 Other distributions (describe in Part VI). See instructions | ||
| 7Total annual distributions. Add lines 1 through 6. | ||
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
||
| 9 Distributable amount for 2014 from Section C, line 6 | ||
| 10 Line 8 amount divided by Line 9 amount | ||
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2014 |
(iii) Distributable Amount for 2014 |
|
|---|---|---|---|---|
|
1
Distributable amount for 2014 from Section C, line 6 |
||||
|
2
Underdistributions, if any, for years prior to 2014 (reasonable cause required--see instructions) |
||||
| 3 Excess distributions carryover, if any, to 2014: | ||||
| a From 2009.......X | ||||
| b From 2010.......X | ||||
| c From 2011.......X | ||||
| d From 2012.......X | ||||
| e From 2013....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2014 distributable amount | ||||
|
i
Carryover from 2009 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from 3f. | ||||
| 4Distributions for 2014 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2014 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from 4. | ||||
|
5
Remaining underdistributions for years prior to 2014, if any. Subtract lines 3g and 4a from line 2 (if amount greater than zero, see instructions) |
||||
|
6
Remaining underdistributions for 2014. Subtract lines 3h and 4b from line 1 (if amount greater than zero, see instructions) |
||||
|
7 Excess distributions carryover to 2015. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a From 2010.......X | ||||
| b From 2011.......X | ||||
| c From 2012.......X | ||||
| d From 2013....... | ||||
| e From 2014....... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.
Information about Schedule O (Form 990 or 990-EZ) and its instructions is at| Return Reference | Explanation |
|---|---|
| Organizational document changes Part VI line 4 | BYLAWS WERE AMENDED AND RESTATED IN JUNE 2016 TO INCLUDE ADDITIONAL CHARITABLE & EDUCATIONAL PURPOSES WHICH IS TO SUPPORT A SPECIALTY PHARMACY IN THE AREA OF REPRODUCTIVE MEDICINE AND PATIENT EDUCATION AND COUNSELING USING SPECIALTY PHARMACY DRUGS. THE SUPPORT AND USE OF SPECIALTY PHARMACY PRODUCTS WOULD ENABLE USE OF GENERIC DELIVERY SYSTEMS & BLINDED STUDIES TO ENHANCE THE INTEGRITY OF THE EXPERIMENTAL DESIGNS USED IN STUDIES EVALUATING PHASES OF THE CLINICAL IVF PROCESS WHICH WOULD ENHANCE EMBRYO QUALITY AND IMPLANTATION RATES. |
| Member election for additional members Part VI line 7a | PART VI - SECTION A- LINE 7ATHE BOARD OF DIRECTORS HAVE THE RIGHT TO APPOINT THE DIRECTORS AND OFFICERS OF THE ORGANIZATION. THE BOARD MEMBERS HAVE 3 YEAR TERMS AND OFFICERS HAVE ONE YEAR TERMS |
| Form 990 governing body review Part VI line 11 | THE DIRECTORS AND FINANCIAL EMPLOYEE RECEIVE A COPY OF THE FORM 990 FOR REVIEW, CORRECTIONS AND COMMENTS |
| Conflict of interest policy compliance Part VI line 12c | THE COMPANY REVIEWS ITS CONFLICT OF INTEREST POLICY WITH ITS DIRECTORS, TRUSTEES AND KEY EMPLOYEES ON A YEARLY BASIS TO MONITOR COMPLIANCE. AN ANNUAL CONFLICT OF INTEREST QUESTIONNAIRE IS COMPLETED BY EACH DIRECTOR AND OFFICER TO ENSURE THAT ANY CONFLICTS ARE IDENTIFIED AND RESOLVED. |
| CEO executive director top management comp Part VI line 15a | PART VI QUESTION 15AIN ARTICLE VII OF THE ORGANIZATIONSS CONFLICT OF INTEREST POLICY - PERIODIC REVIEWS WILL BE CONDUCTED TO ENSURE THE ORGANIZATION OPERATES IN A MANNER CONSISTENT WITH CHARITABLE PURPOSES WHICH WOULD INCLUDE WHETHER COMPENSATION ARRANGEMENTS AND BENEFITS ARE REASONABLE, BASED ON COMPETENT SURVEY INFORMATION , AND THE RESULT OF ARMS LENGTH BARGAINING. WHEN CONDUCTING THIS REVIEW THE ORGANIZATION MAY, BUT NEED NOT, USE OUTSIDE ADVISORS. IF OUTSIDE EXPERTS ARE USED, THEIR USE SHALL NOT RELIEVE THE GOVERNING BOARD OF ITS RESPONSIBILILTY FOR ENSURING PERIODIC REVIEWS ARE CONDUCTED. THROUGH 9/30/15, THE ORGANIZATION USED A MARKET SURVEY TO CONFIRM THE CHIEF OPERATING OFFICERS SALARY. |
| Other officer or key employee compensation Part VI line 15b | PART VI 15(B)SEE ANSWER TO 15(A) - SAME ANSWER IS APPLICABLE TO 15(B) |
| Governing documents etc available to public Part VI line 19 | ALL DOCUMENTS ARE AVAILABLE TO THE PUBLIC BY CONTACTING THE CHIEF OPERATING OFFICER AT:140 ALLEN ROADBASKING RIDGE, NJ 07920THE PUBLIC CAN RECEIVE THIS INFORMATION THROUGH THE FOUNDATIONS WEBSITE WWW.FAEEC.ORG |
| General explanation attachment | PART 1 LINE 1 AND PART III LINE 1 - ORGANIZATIONS MISSIONPROVIDE BROAD ACCESS TO CONTEMPORARY EMBRYO AND SINGLE GENE DEFECT DIAGNOSTICS, WHICH ARE NOT COMMONLY PROVIDED WITHIN ART CLINICS; SPONSOR CLINICAL RESEARCH INTO NEW EMBRYO DIAGNOSTICS; PROVIDE CONTINUING MEDICAL EDUCATION AND GRADUATE FELLOWSHIP EDUCATION RELATED TO THE APPLICATION OF DIAGNOSTICS USED TO ASSESS EMBRYONIC REPRODUCTIVE COMPETENCE. SUPPORT SPECIALTY PHARMACY IN THE AREA OF REPRODUCTIVE MEDICINE, WHICH CAN PROVIDE COMPARATIVE SUPPORT FOR STUDIES WHERE MEDICATIONS NEED TO BE BLINDED. THE SUPPORT OF SPECIALTY PHARMACY IS CRITICAL IN STUDIES EVALUATING PHASES OF THE CLINICAL IVF PROCESS, WHICH WOULD ENHANCE EMBRYO QUALITY OR IMPLANTATION RATES. GIVEN THE VIRTUAL IMPOSSIBILITY OF PERFORMING BLINDED STUDIES IN THE FIELD, DUE TO THE USE OF INJECTABLES AND SUPPOSITORIES WITH SPECIFIC PACKAGING AND DELIVERY MATERIALS, THE SUPPORT AND USE OF SPECIALTY PHARMACY PRODUCTS WOULD ENABLE THE USE OF GENERIC DELIVERY SYSTEMS AND BLINDED STUDIES TO ENHANCE THE INTEGRITY OF THE EXPERIMENTAL DESIGNS USED IN THESE STUDIES. PROVIDE PATIENT EDUCATION REGARDING THE USE OF SPECIALTY PHARMACY DRUGS AND MEDICATIONS IN SUPPORT OF EMBRYONIC AND SINGLE GENE TESTING PROTOCOLS. THE WIDE STREAM DISSEMINATION OF EDUCATIONAL MATERIALS AND PATIENT COUNSELING THROUGH THE FOUNDATION, PRODUCED IN CONJUNCTION WITH SPECIALTY PHARMACIES, WILL ENHANCE AND SUPPORT CURRENT CLINICAL MEDICATIONS AND PROTOCOLS, TEACH, TRAIN AND FOLLOW UP WITH PATIENTS REGARDING POSSIBLE SIDE EFFECTS OR COMPLICATIONS, RESEARCH PROTOCOLS PERFORMED BY THE FOUNDATION, RESULT IN SUPERIOR PATIENT OUTCOMES, AND ENSURE THE LONG TERM SAFETY OF IVF PATIENTS. DEVELOP DIRECT BUSINESS RELATIONSHIPS WITH SPECIALTY PHARMACIES SO AS TO GENERATE SPECIALTY PHARMACY PATIENT DATA FROM ACROSS VARIED DEMOGRAPHIC PLAINS IN ORDER TO PROVIDE THE FOUNDATION TIMELY DATA ON PROTOCOLS, TRENDS, PRESCRIBING PRACTICES AND MANY OTHER POTENTIALLY VALUABLE FACETS OF INFORMATION TO BE USED TO ENHANCE PATIENT OUTCOMES AND RESEARCH PROTOCOLS. |
| Software ID: | |
| Software Version: |